EXHIBIT 99.1
 
Contact:
Doug Farrell
Vice President of Investor Relations
408-731-5285

AFFYMETRIX REPORTS FOURTH QUARTER AND FISCAL YEAR 2013 RESULTS

Santa Clara, Calif.February 5, 2014—Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the three and twelve months ended December 31, 2013.

Results for the three months ended December 31, 2013:

Total revenue was $92.6 million, which included revenue from eBioscience of $20.5 million.
Product revenue was $82.1 million, as compared to product revenue for the fourth quarter of 2012 of $76.4 million, an increase of 7%.
GAAP net income was $9.4 million, or $0.10 per diluted share, as compared to a net loss of $12.3 million, or $0.17 per diluted share, in the fourth quarter of 2012.
Non-GAAP net income was $2.2 million, or $0.02 per diluted share, as compared to a Non-GAAP net loss of $1.3 million, or $0.02 per diluted share, for the fourth quarter of 2012. Please refer to "Itemized Reconciliation Between GAAP and Non-GAAP Net Income (Loss)" for a reconciliation of these GAAP and Non-GAAP financial measures.
Total balance in cash and cash equivalents was $57.1 million at the end of December 31, 2013.

Product revenue for the fourth quarter of 2013 was $82.1 million and service and other revenue was $10.5 million. This compares to product revenue of $76.4 million and service and other revenue of $8.0 million in the fourth quarter of 2012. Product revenue for the fourth quarter of 2013 included Affymetrix core consumable revenue of $57.6 million, instrument revenue of $4.0 million and revenue from eBioscience of $20.5 million. Product revenue for the fourth quarter of 2012 included Affymetrix core consumable revenue of $53.1 million and instrument revenue of $5.2 million and revenue from eBioscience of $18.1 million.

Total gross margin was 59%, as compared to 54% in the same period of 2012. Excluding Non-GAAP adjustments such as the amortization of step-up in inventory fair value and one-time licensing payment, total margin was 62% compared to 61% for the fourth quarter of 2012. Please refer to the "Itemized Reconciliation Between GAAP and Non-GAAP Gross Margin" for a reconciliation of these GAAP and Non-GAAP financial measures.

For the fourth quarter of 2013, operating expenses were $51.1 million on a GAAP basis as compared to $54.4 million in 2012. Excluding Non-GAAP adjustments such as the amortization of acquired intangible assets and non-recurring charges, operating expenses were $47.9 million, compared to an adjusted total of $48.5 million in 2012. The decrease in 2013 is primarily driven by lower headcount following the restructuring announced on January 11, 2013 and due to non-recurring acquisition- and integration-related costs incurred during 2012 partially off-set by higher variable compensation expenditure. Please refer to the "Itemized Reconciliation Between GAAP and Non-GAAP Operating Expenses" for a reconciliation of these GAAP and Non-GAAP financial measures.

Results for the year ended December 31, 2013:

Total revenue was $330.4 million, which included eBioscience of $78.2 million, compared to total revenue of $295.6 million in 2012, which included eBioscience revenue of $37.0 million.
GAAP net loss was $16.3 million, of $0.23 per diluted share, as compared to a net loss of $10.7 million, or $0.15 per diluted share, in 2012.
Non-GAAP net income was $7.4 million, or $0.10 per diluted share, as compared to a net loss of $6.8 million, or $0.10 per diluted share, for 2012. Please refer to the “Itemized Reconciliation Between GAAP and Non-GAAP Net Loss” for a reconciliation of these GAAP and non-GAAP financial measures.



The following information was filed by Affymetrix Inc (AFFX) on Wednesday, February 5, 2014 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Affymetrix Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Affymetrix Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account